Cargando…
Bacterial vaginosis: drivers of recurrence and challenges and opportunities in partner treatment
Bacterial vaginosis (BV) is the most common vaginal dysbiosis to affect women globally, yet an unacceptably high proportion of women experience BV recurrence within 6 months of recommended antibiotic therapy. The low rate of sustained cure highlights our limited understanding of the pathogenesis of...
Autores principales: | Vodstrcil, Lenka A., Muzny, Christina A., Plummer, Erica L., Sobel, Jack D., Bradshaw, Catriona S. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8411528/ https://www.ncbi.nlm.nih.gov/pubmed/34470644 http://dx.doi.org/10.1186/s12916-021-02077-3 |
Ejemplares similares
-
The Role of Antimicrobial Resistance in Refractory and Recurrent Bacterial Vaginosis and Current Recommendations for Treatment
por: Muzny, Christina A., et al.
Publicado: (2022) -
A Prospective, Open-Label Pilot Study of Concurrent Male Partner Treatment for Bacterial Vaginosis
por: Plummer, Erica L., et al.
Publicado: (2021) -
Treating male partners of women with bacterial vaginosis (StepUp): a protocol for a randomised controlled trial to assess the clinical effectiveness of male partner treatment for reducing the risk of BV recurrence
por: Vodstrcil, Lenka A., et al.
Publicado: (2020) -
Combined oral and topical antimicrobial therapy for male partners of women with bacterial vaginosis: Acceptability, tolerability and impact on the genital microbiota of couples - A pilot study
por: Plummer, Erica L., et al.
Publicado: (2018) -
Combined oral contraceptive pill-exposure alone does not reduce the risk of bacterial vaginosis recurrence in a pilot randomised controlled trial
por: Vodstrcil, Lenka A., et al.
Publicado: (2019)